Skip main navigation (Press Enter).

Announcements

Comment on Draft FDA Guidance Until April 11

By: Kathy Robinson , 3 years ago

The agency issued draft guidance to provide recommendations to companies developing non-opioid analgesics for acute pain lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery. This guidance supports the HHS Overdose Prevention Strategy, which focuses on four priority areas — primary prevention, harm reduction, evidence-based treatment and recovery support.
#GeneralDiscussion

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-non-opioid-analgesics-acute-pain-draft-guidance-industry

Powered by Higher Logic

Global message icon